Acuta Capital Partners as of June 30, 2024
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 33 positions in its portfolio as reported in the June 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ocular Therapeutix (OCUL) | 16.0 | $19M | 2.8M | 6.84 | |
Enliven Therapeutics (ELVN) | 7.8 | $9.3M | 398k | 23.37 | |
Vaxcyte (PCVX) | 7.0 | $8.3M | 110k | 75.51 | |
Dyne Therapeutics (DYN) | 6.3 | $7.5M | 213k | 35.29 | |
Praxis Precision Medicines I (PRAX) | 5.7 | $6.8M | 164k | 41.36 | |
Crinetics Pharmaceuticals In (CRNX) | 5.1 | $6.1M | 135k | 44.79 | |
Rocket Pharmaceuticals (RCKT) | 4.5 | $5.4M | 250k | 21.53 | |
Taysha Gene Therapies Com Shs (TSHA) | 4.4 | $5.2M | 2.3M | 2.24 | |
Revolution Medicines (RVMD) | 4.3 | $5.2M | 133k | 38.81 | |
Insmed Com Par $.01 (INSM) | 4.1 | $4.8M | 72k | 67.00 | |
Sarepta Therapeutics (SRPT) | 3.7 | $4.3M | 28k | 158.00 | |
Tourmaline Bio (TRML) | 2.9 | $3.5M | 270k | 12.86 | |
Agios Pharmaceuticals (AGIO) | 2.9 | $3.4M | 79k | 43.12 | |
Kura Oncology (KURA) | 2.8 | $3.4M | 163k | 20.59 | |
Mersana Therapeutics (MRSN) | 2.8 | $3.3M | 1.7M | 2.01 | |
Corbus Pharmaceuticals Holdi Com New (CRBP) | 2.5 | $2.9M | 65k | 45.25 | |
Aadi Bioscience (AADI) | 2.3 | $2.7M | 1.8M | 1.46 | |
Miragen Therapeutics (VRDN) | 2.2 | $2.6M | 199k | 13.01 | |
Terns Pharmaceuticals (TERN) | 2.1 | $2.5M | 369k | 6.81 | |
Mereo Biopharma Group Pl- Spon Ads (MREO) | 2.1 | $2.4M | 677k | 3.60 | |
Arcellx Common Stock (ACLX) | 2.0 | $2.3M | 42k | 55.19 | |
Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 1.5 | $1.8M | 178k | 10.22 | |
Argenx Se Sponsored Adr (ARGX) | 1.4 | $1.7M | 4.0k | 430.04 | |
Trevi Therapeutics (TRVI) | 0.7 | $775k | 260k | 2.98 | |
Celcuity (CELC) | 0.6 | $737k | 45k | 16.38 | |
Oric Pharmaceuticals (ORIC) | 0.6 | $679k | 96k | 7.07 | |
Pliant Therapeutics (PLRX) | 0.4 | $497k | 46k | 10.75 | |
Rapport Therapeutics (RAPP) | 0.4 | $465k | 20k | 23.26 | |
Newamsterdam Pharma Co Nv Ordinary Shares (NAMS) | 0.4 | $432k | 23k | 19.21 | |
Leap Therapeutics Com New (LPTX) | 0.3 | $382k | 195k | 1.96 | |
Cellectar Biosciences Com New (CLRB) | 0.1 | $176k | 71k | 2.50 | |
Savara Put Option (SVRA) | 0.1 | $101k | 250.00 | 403.00 | |
Nuvation Bio Inc -cw27 *w Exp 07/07/2027 (NUVB.WS) | 0.0 | $15k | 91k | 0.16 |